Adjuvant chemotherapy following chemoradiation did not prolong OS or PFS compared with chemoradiation alone among women with locally advanced cervical cancer, according to results of the randomized phase 3 OUTBACK study. In addition, women who received adjuvant chemotherapy experienced more grade 3 to grade 5 adverse events and worse quality of life up to 6 months after treatment, according to